Cadila Healthcare informs about press release

29 Dec 2017 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Clomipramine Hydrochloride Capsules USP.’

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

944.25 -2.65 (-0.28%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.